| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.59B | +10.7% | +23.3% |
| Cost of Revenue | $237.7M | -7.8% | +6.5% |
| Gross Profit | $1.35B | +14.8% | +26.8% |
| R&D Expense | $826.5M | +9.3% | +21.5% |
| SG&A Expense | $193.4M | +8.3% | +14.7% |
| Operating Income | -$47.7M | +50.4% | +16.9% |
| Pre-tax Income | -$55.8M | +1.0% | -18.2% |
| Income Tax | -$13.1M | -194.4% | -46.1% |
| Net Income | -$42.6M | +17.8% | -11.6% |
| EPS (Basic) | -$0.16 | +20.0% | -6.7% |
| EPS (Diluted) | -$0.16 | +20.0% | -6.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.16B | -50.1% | -47.8% |
| Short-term Investments | $407.9M | -10.5% | +62.1% |
| Accounts Receivable | $911.9M | +69.9% | +31.1% |
| Current Assets | $2.78B | -23.5% | -16.4% |
| Total Assets | $6.16B | +7.7% | +13.1% |
| Current Liabilities | $3.12B |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $177.8M | +38.1% | -49.5% |
| Capital Expenditures | $9.3M | -34.2% | -0.5% |
| Investing Cash Flow | -$1.14B | -1784.9% | -924.0% |
| Financing Cash Flow | -$197.4M | +21.9% | -185.1% |
| Free Cash Flow | $168.5M | +47.0% | -50.8% |
| +16.1% |
| Long-term Debt | $988.6M | +0.0% | +0.2% |
| Total Liabilities | $4.57B | +5.3% | +8.1% |
| Stockholders' Equity | $1.59B | +15.4% | +30.4% |